About: Association of antibody to E2 protein of human papillomavirus and p16 with progression of HPV-infected cervical lesions

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Association of antibody to E2 protein of human papillomavirus and p16 with progression of HPV-infected cervical lesions Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 May 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2018 (uk) im Mai 2018 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2018 (fr) artículu científicu espublizáu en mayu de 2018 (ast) scientific article published on 09 May 2018 (en)
publication date	wds:Q59361060-DAC816B8-215F-496F-9448-DDF00DEEB641
publication date	2018-05-09 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59361060-E3723658-A294-45BF-BB95-471D94A8B509
language of work or name	English
cites work	wds:Q59361060-046B697D-9587-47BA-B77B-C59976E2B45E wds:Q59361060-0BCCC71A-AEED-4582-99DB-07C7B8BE3124 wds:Q59361060-12402652-E05A-4646-A5E6-E9315867FA99 wds:Q59361060-13E7138C-DFA3-42F4-9692-A010BD6C09AA wds:Q59361060-1B90B6FB-EBB7-4848-B7A5-77382A6782B4 wds:Q59361060-217D6BC9-91C2-491E-BA10-5B4A017E8887 wds:Q59361060-276168C3-B2E9-47A2-9C13-511AA4E68B3B wds:Q59361060-2DF4B0A0-CD09-4F43-ACF2-22A400A0EE02 wds:Q59361060-2F02D281-4D1A-4B59-A87E-1C14B50A71EC wds:Q59361060-35E7DE24-68C1-4D41-BE88-EB0FD816C1F3 wds:Q59361060-3EE3B793-999D-4C7E-BCE4-B4C3CB2445A2 wds:Q59361060-3FA91220-2FAE-4F9A-9CF8-12145335FDEC wds:Q59361060-440A3DE6-42C6-48C2-B7E4-6EA788CA4649 wds:Q59361060-46C38F9D-AF80-4758-9950-BD3DDC6BC30D wds:Q59361060-4C259D53-B0F0-44E3-AEBA-0AA001F8EB92 wds:Q59361060-4EB809D3-A3DB-4C66-A802-23F84A219011 wds:Q59361060-4EF5D702-A63D-4CFC-AB54-A9A8680DBAFD wds:Q59361060-514450EF-E2D7-4ECA-B19D-5D5A2E01E84D wds:Q59361060-54631807-3919-4FB4-83E1-229E77C281C1 wds:Q59361060-5FD711AD-859B-4A95-9AF5-B443A0687245 wds:Q59361060-61A3C70B-BE86-4521-A943-758126EB0049 wds:Q59361060-66679949-0A94-4A98-B49E-22F2DD5E7690 wds:Q59361060-6D2A7B9C-FF5B-43E4-A2C2-B1645DC7C6B0 wds:Q59361060-7AB5AE3C-06A8-4D5D-9352-C66AF0E49CBE wds:Q59361060-7C7A6D45-79A8-484F-8DBA-8C1ACB1A1BE0 wds:Q59361060-7DF5B079-4710-4D16-B9C1-F9FBD68E903D wds:Q59361060-917C8746-E713-4AC1-B182-47A0ACC08ECF wds:Q59361060-9C1B1EE1-AA25-4CAA-895B-AAD674C88D09 wds:Q59361060-A1707364-5762-4B79-BB9E-E08C95EC8F16 wds:Q59361060-A286C9E9-3AD6-40F3-9872-D350912D4B96 wds:Q59361060-ABB7D3C6-593E-444D-8270-8A8D3B9E32C7 wds:Q59361060-AEA5BC02-2147-4720-882E-07C700437666 wds:Q59361060-B8713101-A030-425C-AB71-CCFD5C227641 wds:Q59361060-BD2F6543-75D5-4543-9A3F-E541C4AA5A31 wds:Q59361060-C6DE1B93-6830-4900-99F0-1A9DBEB77E81 wds:Q59361060-DECDE2EF-DE6B-4D5A-9D63-0740DEFD0B3E wds:Q59361060-E3995B20-BDA8-4750-8952-D5315522FFAE wds:Q59361060-E6DA2EAB-FF0B-4A36-AAF2-E0CB00C447E8 wds:Q59361060-E8B1E8AD-26E1-4F90-9B67-C4F345958693 wds:Q59361060-EF620230-2BCE-40A3-9DEA-3244576FB551 wds:Q59361060-FB5A5B42-DAF7-46BA-A2BE-5ED3154C5998 wds:Q59361060-FFEC63AD-B78C-488F-A7D8-092B119A6405
cites work	Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects. HPV: from infection to cancer HPV - immune response to infection and vaccination New paths in human cancer serology The laboratory diagnosis of genital human papillomavirus infections Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses Human papillomavirus infection: biology, epidemiology, and prevention Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status Human papillomavirus proteins as prospective therapeutic targets Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer Human Papillomavirus and the DNA Damage Response: Exploiting Host Repair Pathways for Viral Replication Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA. Characterization of IgA response among women with incident HPV 16 infection Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma Advantages and disadvantages of current prophylactic vaccines against HPV. Circulating antibodies to p16 protein-derived peptides in breast cancer Serum Immune Profiling for Early Detection of Cervical Disease. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia.
author name string	wds:Q59361060-8002E2E8-B7E2-45AA-A67E-2F89E957914D wds:Q59361060-9B3B8FC5-1BBD-49AF-B681-7C08FFA47973 wds:Q59361060-A765C873-F356-4317-BDBF-2D17225D4065 wds:Q59361060-C59F3CDD-34FD-48CF-B987-755A30DB7FF4 wds:Q59361060-CC275397-747D-484E-8E04-0B80772E4128

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software